my.bionity.com
With an accout for my.bionity.com you can always see everything at a glance – and you can configure your own website and individual newsletter.
30-05-2012: Biocartis announces that its researchers, in collaboration with researchers at the Wellcome Trust Sanger Institute and at Philips Research, are developing a novel workflow for extraction and amplification & detection of tumor DNA on Biocartis diagnostic platforms. Biocartis retains its full IP rights, with access to IP created during the scope of this collaboration. The availability of this test is expected to have a major impact on personalizing treatment of tumors, increasing the quality of clinical care and the quality of life for the patient. Individual decisions on treatment duration and intensity will be in reach and ultimately, this could allow drugs to be targeted to only those patients who show meaningful response, reducing unnecessary side-effects and improving effectiveness.
Dr Patrick van den Bogaard, Director of Life Science Research at Biocartis SA comments: “The system will use disposable, microfluidic cartridges with digitally encoded micro particles for the rapid and sensitive detection of multiple DNA samples. The test aims to be highly specific and sensitive, being able to isolate and detect just a few molecules of tumor DNA per ml of blood. To implement such tests in a real-world healthcare system requires development of fully automated, high multiplexing diagnostic instruments and technology which is the core focus of Biocartis.”
Contact / Request information
Request further information free of charge:
Watchlist
This is where you can add this news to your personal favourites
Biocartis strengthens management team with general counsel
Biocartis announced that Inge Basteleurs has joined the company as General Counsel. Inge will be a member of Biocartis’ Executive Committee and a director of Biocartis NV. Inge Basteleurs brings to Biocartis a 17-year career as a senior international executive within the biotechnology and p ... more
Biocartis collaborates with Philips and Wellcome Trust in oncology diagnostics
Biocartis announces that its researchers, in collaboration with researchers at the Wellcome Trust Sanger Institute and at Philips Research, are developing a novel workflow for extraction and amplification & detection of tumor DNA on Biocartis diagnostic platforms. Biocartis retains its full ... more
Biocartis appoints Clark Harrison as Chief Operating Officer
Biocartis announced the appointment of Clark Harrison as its new Chief Operating Officer. Clark is the first senior appointment following the announcement of new CEO Greg Parekh.Parekh’s move to add Clark to his top management team, marks a new phase for the company as it strengthens produ ... more
Biocartis is a privately owned biotech company that was founded in 2007 by Dr. Rudi Pauwels (Co-founder of Tibotec, Virco and Galapagos Genomics), Prof. Philippe Renaud (Prof. at EPFL), and Nader Donzel (Co-founder of Scitec laboratory Automation). Biocartis engages in the development of no ... more
Biocartis collaborates with Philips and Wellcome Trust in oncology diagnostics
Biocartis announces that its researchers, in collaboration with researchers at the Wellcome Trust Sanger Institute and at Philips Research, are developing a novel workflow for extraction and amplification & detection of tumor DNA on Biocartis diagnostic platforms. Biocartis retains its full ... more
Phagenesis Wins c. £1 million Translation Award by Wellcome Trust to Expand Dysphagia Treatment
Phagenesis Ltd has been awarded c. £1 million from the Wellcome Trust to extend the scope of its dysphagia treatment device, from hospitals into the community. The Phagenesis technology is designed to treat patients who are dysphagic following a stroke.Dysphagia affects more than one mil ... more
Canbex Therapeutics receives £1.75 million Translation Award from the Wellcome Trust
Canbex Therapeutics Ltd. announced today that it has received a Translation Award of up to 1.75 million ($2.8 million) from the Wellcome Trust to support development of a drug for the treatment of the debilitating muscle spasms associated with multiple sclerosis and potentially other disord ... more
The Wellcome Trust is the largest charity in the UK. It funds innovative biomedical research, in the UK and internationally, spending around £650 million each year to support the brightest scientists with the best ideas. The Wellcome Trust supports public debate about biomedical research an ... more
Biocartis collaborates with Philips and Wellcome Trust in oncology diagnostics
Biocartis announces that its researchers, in collaboration with researchers at the Wellcome Trust Sanger Institute and at Philips Research, are developing a novel workflow for extraction and amplification & detection of tumor DNA on Biocartis diagnostic platforms. Biocartis retains its full ... more
Philips and Dako join forces in digital pathology
Royal Philips Electronics and Dako announced that they have signed an agreement to integrate a selection of Dako's image analysis applications into Philips' future digital pathology solutions. "Anatomic pathology is an essential element of virtually every cancer diagnosis and the demand fo ... more
Organon and Philips team up to study drug effects at the molecular level
N.V. Organon, the human health care business unit of Akzo Nobel, and Royal Philips Electronics announced that they will join forces in the development of new drugs and therapies for mental disorders and cancer. With the help of biomarkers and Philips' advanced non-invasive medical imaging t ... more
Über CHEMIE.DE
CHEMIE.DE Information Service GmbH runs specialist scientific internet portals. The secret to our success? We are familiar with what we publish.
Advertising at CHEMIE.DE
Our advertising formats support you in getting your message across to a clearly defined target audience.
© 1997-2013 CHEMIE.DE Information Service GmbH, All rights reserved
Netmeeting
